Navigation Links
Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
Date:3/10/2008

Preclinical Studies Demonstrate a Viable Intravenous Inosine Formulation

and Support Oral Dosing for Three Alseres' DAT Blocker Compounds

HOPKINTON, Mass., March 10 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE) announced that data from preclinical studies of the Company's nerve repair candidate, Inosine, and DAT Blocker product candidates from its neurodegeneration program were presented at the ASENT conference, March 6-8, 2008 in Arlington, VA.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070608/NEF043LOGO )

The first poster presentation entitled: "Brain microdialysate and plasma concentrations of Inosine during intravenous Inosine infusion in conscious rats" highlighted the results of a central nervous system (CNS) microdialysis study designed to measure the levels of Inosine in the brain during intravenous infusion of high concentrations of Inosine. The results suggest that Inosine infused intravenously was measurably able to cross the blood- brain barrier. Inosine is a nerve regenerative factor that has been shown to promote axon outgrowth in neurons and has potential to be used to treat CNS disorders such as stroke, spinal cord injury and traumatic brain injury.

"The literature suggests that Inosine can cross the blood-brain barrier, however, no direct measurements of brain levels of Inosine during systemic dosing have been previously reported," commented Noel Cusack, Ph.D, Alseres' Senior Vice President of Preclinical Development. "This study shows that when administered intravenously using our new, highly-concentrated Inosine formulation, Inosine levels in the brain increased more than 600%,
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
2. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
3. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
4. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results and Clinical Program Overview on March 12, 2008
5. Jazz Pharmaceuticals, Inc. Announces Webcast of March 13 Investor Meeting
6. ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results
7. ADVENTRX Pharmaceuticals to Report Fourth Quarter and Year End 2007 Results
8. Acura Pharmaceuticals, Inc. Reports 2007 4th Quarter and Annual Financial Results; Sets 2008 Expectations
9. Sunesis Pharmaceuticals to Present Interim Phase 2 Data for SNS-595 at the 39th Annual Meeting on Womens Cancer
10. Peregrine Pharmaceuticals to Announce Third Quarter FY 2008 Financial Results
11. MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... BioTrends Research Group, one of the ... biopharmaceutical issues, finds that, unaided, one in five ... that in the past six months, they have ... anticipation of the next generation of HCV treatments—notably ... 6 percent reported that they had begun warehousing ...
(Date:5/23/2013)... BETHESDA, Md. , May 23, 2013 ... a biotechnology company developing DCVax ® personalized immune ... will use its exhibit at this year,s American Society ... to highlight its leadership role in immune ... The ASCO annual meeting is the pre-eminent conference ...
(Date:5/23/2013)...  Verenium Corporation (Nasdaq: VRNM ), a ... commercialization of high-performance enzymes, today announced that ... at two upcoming conferences. (Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO ... Second Annual Marcum LLP Microcap Conference on Thursday, May ... York City.  The presentation is scheduled to begin at ...
(Date:5/23/2013)... 23, 2013 SynCardia Systems, Inc. ( ... FDA, Health Canada and CE (Europe) approved Total Artificial ... Scotland, which boasts more than 380,000 visitors annually, is ... powered by the Freedom® portable driver as part of ... advanced exhibitions of its kind. , “BodyWorks combines ...
Breaking Biology Technology:The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3
... ... ... ... ...
... ... ... ... ...
... ... ... ... ...
Cached Biology Technology:Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 2Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 3Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 4Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 5Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 6Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 7MO BIO Laboratories, Inc. Launches PowerBiofilm(TM) DNA and RNA Isolation Kits 2MO BIO Laboratories, Inc. Launches PowerBiofilm(TM) DNA and RNA Isolation Kits 3Concord Medical to Report Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Thursday, March 18, 2010 2Concord Medical to Report Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Thursday, March 18, 2010 3Concord Medical to Report Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Thursday, March 18, 2010 4Concord Medical to Report Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Thursday, March 18, 2010 5Concord Medical to Report Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Thursday, March 18, 2010 6
(Date:5/24/2013)... of the world,s largest and fastest growing open-access publishers, ... Frontiers in Physics . , A broad scope journal ... provide an open-science and interactive web platform for the ... articles. , Frontiers, real-time and interactive peer-review enables ... article types. With an average of three months from ...
(Date:5/24/2013)... by avoiding detection and destruction by the immune system. ... cancer cells; however, there are many factors that cause ... cells are immune cells that function to suppress the ... Journal of Clinical Investigation , researchers led by Ronald ... that infiltrate tumors express proteins that can be targeted ...
(Date:5/24/2013)... one French Quarter neighborhood of New Orleans to determine ... Hurley, PhD, Assistant Professor of Audiology at LSU Health ... LSUHSC doctor of audiology student, recommend that people use ... case study is published online in the current issue ... important part of an audiologist,s practice is aiding patients ...
Breaking Biology News(10 mins):Frontiers launches new open-access journal in physics 2Frontiers launches new open-access journal in physics 3Please do try this at home 2
... changed its wing patterns to mimic neighbouring species and avoid ... of European scientists. The study is published today (14 August ... evolutionary thinkers, including Wallace, Bates and Darwin, have all wondered ... same patterns of warning colouration. Now for the first time, ...
... A new study shows that as climate change enhances ... could stimulate soil micro-organisms leading to a release of stored ... from the Centre for Ecology & Hydrology and the University ... August 2011) in the scientific journal Nature Climate Change ...
... Lithuania, July 6, 2011 Neurotechnology , ... introduced VeriSpeak , the company,s new voice ... VeriSpeak Software Development Kit (SDK) and as a ... 4.1 multi-biometric SDK, also announced today. VeriSpeak combines ...
Cached Biology News:Research reveals how butterflies copy their neighbors to fool birds 2Increased tropical forest growth could release carbon from the soil 2Neurotechnology Introduces VeriSpeak Voice Identification Technology 2Neurotechnology Introduces VeriSpeak Voice Identification Technology 3Neurotechnology Introduces VeriSpeak Voice Identification Technology 4
...
... Fixed clamp trays and universal ... Magnetic drive Shaking ... 25 mm amplitude ... to 2000 ml, including Fernbach flasks ...
... and Sartolab P20 plus,for Reliable Sterile Filtration ... attached to a,membrane pump or tube pump, ... liter of media,and aqueous solutions. The ... and an automatic de-aeration,ensures high flow rates ...
... allows for rapid, convenient, and efficient Denatured ... process utilizes a spin column to make ... concentration of proteins which were electro-eluted in ... ion exchangers, offering high binding capacity fo ...
Biology Products: